Trade Spotlight: How should you trade Emcure Pharma, Alkem Laboratories, Indus Towers, Titan, Torrent Pharma, and others on January 9?

Top Buy Ideas for January 9

• Experts recommend buying 9 stocks on January 9 including Emcure Pharma, Alkem Laboratories, Indus Towers, Titan, Torrent Pharma

Did our AI summary help?

Equity benchmarks dropped 1 percent on January 8, extending the losing streak for the fourth straight session, with bears dominating market breadth. About 2,470 shares declined compared to 439 shares that gained on the NSE. The market is expected to consolidate with range-bound trading after the sharp correction. Below are some short-term trading ideas to consider:

Aakash Shah, Research Analyst at Choice Broking

Alkem Laboratories | CMP: Rs 5,793

On the daily chart, price action in Alkem Laboratories has formed a descending channel, indicating a corrective move within a broader uptrend rather than a trend reversal. The recent strong bullish candle has broken above the upper trendline of the channel, signalling a resumption of bullish momentum.

The stock is trading above the 20 EMA and 50 EMA, both of which are sloping upward, reflecting strengthening short-term and medium-term momentum. The price is also comfortably placed above the 100 EMA and 200 EMA, confirming that the broader trend remains bullish and structurally intact.

Volume has expanded on the breakout, supporting the validity of the move, while volumes were relatively muted during the consolidation phase — a classic sign of healthy price digestion before continuation.

From a momentum perspective, the RSI is trending above 60, indicating bullish strength without entering extreme overbought territory, leaving room for further upside. Structurally, the Rs 5,550–5,600 zone now acts as a key support area, aligning with the breakout level and short-term moving averages. As long as Alkem holds above this zone, the bullish breakout remains valid and favours continuation toward the Rs 5,900–6,050 resistance zone in the near term.

Strategy: Buy

Target: Rs 6,050

Stop-Loss: Rs 5,550

Supriya Lifescience | CMP: Rs 765

On the daily chart, price action in Supriya Lifescience is forming a rising channel, indicating higher lows and sustained buying interest after the prior impulse move. The recent bounce from the lower boundary of the channel near Rs 720–730 reflects demand absorption and signals continuation potential.

The stock is trading above the 20 EMA and 50 EMA, both of which are gradually turning upward, reflecting improving short-term momentum. The price is also holding above the 100 EMA and 200 EMA, confirming that the broader trend remains positive and structurally strong. Volume expanded during the earlier breakout toward the Rs 800 zone, while the current consolidation phase is accompanied by relatively lower volumes, highlighting healthy price digestion rather than distribution.

Momentum indicators remain neutral to positive, with the RSI holding above 50, suggesting a bullish bias with scope for further upside as momentum builds.

Structurally, the Rs 730 zone acts as a key demand and support area, aligning with the rising trendline and short-term moving averages. As long as Supriya holds above this zone, the bullish structure remains intact and favours continuation toward the Rs 800–830 resistance zone in the near term.

Strategy: Buy

Target: Rs 830

Stop-Loss: Rs 730

Emcure Pharmaceuticals | CMP: Rs 1,521.8

On the daily chart, Emcure is indicating a sequence of higher lows and steady accumulation after a breakout from its consolidation phase. The recent breakout above the upper range of consolidation near Rs 1,470–1,500 reflects renewed buying interest and strengthens the continuation outlook.

The stock is trading comfortably above its key EMAs, all of which are positively aligned and sloping upward. This EMA structure confirms strong short-term momentum as well as a healthy medium-to-long-term trend, suggesting sustained bullish strength.

Volume activity expanded during the recent upside breakout, while prior consolidation phases were marked by relatively muted volumes, indicating healthy price digestion rather than distribution.

From a momentum perspective, the RSI is trending above 65, indicating bullish strength without entering extreme overbought territory, leaving room for further upside.

From a structural perspective, the Rs 1,430–1,450 zone acts as an important support area, aligning with the short-term EMAs and the prior breakout level. As long as Emcure holds above this support band, the bullish structure remains intact and favours further upside toward the Rs 1,580–1,650 resistance zone in the near term.

Strategy: Buy

Target: Rs 1,650

Stop-Loss: Rs 1,430

Om Mehra, Technical Research Analyst at Samco Securities

Indus Towers | CMP: Rs 430.85

Indus Towers continues to trade in an upward sequence, forming higher highs and higher lows on the daily chart. The stock is holding comfortably above its key moving averages and remains aligned with the rising Supertrend zone, which continues to act as a reliable support. Recent candles near the Rs 425 area are providing a cushion for the short-term correction.

The daily RSI is placed near 61, remaining in the higher zone and indicating sustained strength without any signs of exhaustion. The rate of change indicator also remains in positive territory, supporting the continuation of the ongoing trend. Volumes have remained steady and strong during the advance, suggesting healthy participation.

The broader outlook remains favourable. A sustained move above Rs 435 could open the path for further upside toward higher levels.

Strategy: Buy

Target: Rs 458

Stop-Loss: Rs 414

Ramco Cements | CMP: Rs 1,082.5

Ramco Cements has gradually improved its short-term trend and is now holding above its rising 20-day moving average, while the 50-day average near the Rs 1,040 zone continues to act as a strong base. The stock has been forming higher lows over the past few weeks and is consolidating just below the Rs 1,080–1,090 resistance band.

The daily RSI is placed near 64, indicating sustained strength. The MACD continues to move higher and is in positive territory, supporting the ongoing recovery phase. Volumes have remained steady, suggesting measured participation. As long as the stock holds above Rs 1,055, the near-term outlook remains positive. A sustained move above Rs 1,090 could open the path for further upside.

Strategy: Buy

Target: Rs 1,160

Stop-Loss: Rs 1,040

Endurance Technologies | CMP: Rs 2,611.2

Endurance Technologies is inching higher after a prolonged corrective phase and is now attempting to build a base above the Rs 2,550–2,580 zone. The stock is trading close to its short-term moving average and has started forming higher lows on the daily chart. The long-term 200-day moving average remains near the Rs 2,450 area, providing a broader support base.

The daily RSI, currently around 42, has moved higher from lower levels, pointing to a gradual improvement in momentum. The MACD remains below the zero line but is flattening, suggesting that downside pressure is easing. Volumes have remained slightly muted but may pick up in the coming sessions. As long as the stock holds above Rs 2,550, the near-term outlook remains steady.

Strategy: Buy

Target: Rs 2,750

Stop-Loss: Rs 2,530

Aditya Thukral, Founder & Analyst at AT Research & Risk Managers

GMR Airports | CMP: Rs 102.51

GMR Airports is in an uptrend, marked by the formation of higher highs and higher lows. It has also exhibited a cup-like rounding pattern and witnessed a breakout from this pattern on November 18, 2025, accompanied by a rise in volumes. Since then, prices have been sustaining above the breakout levels and are currently in a consolidation phase. An uptrend continuation is expected as the consolidation nears completion. The stock is consistently trading above all its major EMAs — the 20-day, 50-day, 100-day, and 200-day.

At the same time, the 14-period RSI has cooled off from the overbought zone, which provides further comfort to buyers looking to enter. Short-term traders or investors can consider buying in the range of Rs 101–102, with a stop-loss below Rs 94.65, targeting Rs 115 over the next one month.

Strategy: Buy

Target: Rs 115

Stop-Loss: Rs 94.60

Titan Company | CMP: Rs 4,249

Titan witnessed a breakaway gap in the stock accompanied by a rise in volumes. The stock had already broken above its all-time highs prior to this move and is now accelerating upward. The stock is in a strong uptrend across all major timeframes. An uptrend continuation is expected in the near term after a minor correction in prices. The stock is consistently trading above all its major EMAs — the 20-day, 50-day, 100-day, and 200-day.

At the same time, the 14-period RSI has cooled off from the overbought zone on the hourly timeframe, providing comfort to short-term buyers. Short-term traders or investors can consider buying in the range of Rs 4,190–4,220, with a stop-loss below Rs 4,078, as breakaway gaps generally do not get filled. Prices of around Rs 4,500 are expected to be seen over the next one month.

Strategy: Buy

Target: Rs 4,500

Stop-Loss: Rs 4,075

Torrent Pharmaceuticals | CMP: Rs 4,026.4

Torrent Pharmaceuticals has given a breakout from a box-like consolidation formed after an uptrend. A fresh all-time high breakout was observed along with the breakout from the box pattern, accompanied by a rise in volumes, which is a clear bullish signal. The stock is in an uptrend, forming higher highs and higher lows across all major timeframes. An uptrend continuation is expected in the near term, as acceleration is visible in the current trend. The stock is consistently trading above all its major EMAs — the 20-day, 50-day, 100-day, and 200-day.

At the same time, the 14-period RSI has cooled off from the overbought zone on the hourly timeframe, providing comfort to short-term buyers. Short-term traders or investors can consider buying in the range of Rs 3,980–4,005, with a stop-loss below Rs 3,874, which represents the higher low of the current rally. Prices of around Rs 4,250 are expected to be seen over the coming one month.

Strategy: Buy

Target: Rs 4,250

Stop-Loss: Rs 3,870